Sweden's Episurf Q1 net sales jump

Episurf Medical AB

25/05/2026 06:09

Overview

Sweden property and medtech firm's Q1 net sales rose sharply, but net loss widened

Company completed first property acquisitions as part of shift to cash flow-oriented model

Episurf announced further large property acquisitions and a strategic review of its medtech business after quarter-end

Outlook

Episurf aims to build a larger Nordic property platform focused on stable cash flows and high yield

Company plans further property acquisitions, including four portfolios with total value of SEK 2.6 bln

Company is conducting a dual-track strategic review of its medical technology business

Result Drivers

PROPERTY ACQUISITIONS - Co said Q1 marked the start of its transformation into a property company, with first acquisitions completed at underlying property value of about SEK 270m

Company press release: ID:nWkr8qvrX6

Key Details

Metric
Beat/Miss
Actual
Consensus Estimate
Q1 Sales
SEK 8.80 mln
Q1 EPS
-SEK 0.01
Q1 Net Income
-SEK 26.90 mln


Analyst Coverage

Wall Street's median 12-month price target for Episurf Medical AB is SEK0.07, about 58.9% below its May 22 closing price of SEK0.17

For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)